HIV/AIDS model for assessing the effects of prophylactic sterilizing vaccines, condoms and treatment with amelioration

Journal of Biological Systems

Volumn 14, Issue 3, 2006, Pages 323-355

  Mukandavire, Z ^a   Garira, W ^a  

^a NATIONAL UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Zimbabwe)

Author keywords

Basic Reproductive Number; Condoms; Delay; HIV AIDS Model; Prophylactic Vaccination; Stability; Treatment with Amelioration

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33748560441     PISSN: 02183390     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0218339006001878     Document Type: Article

References (62)

1. May RM, Anderson RM, The transmission dynamics of Human Immunodeficiency Virus (HIV), Philos Trans R. S Land B Biol Sci 321:565-607, 1998.
2. Report on the Global HIV/AIDS Epidemic, UNAIDS and WHO, 1998.
3. Clinical Research on HIV Vaccines, NIAID, www.niaid.nih.gov/factsheets. htm (2005).
4. Blower SM, Bodine EN, Grovit-Ferbas K, Predicting the potential public health impact of disease-modifying HIV vaccines in South Africa: the Problem subtype, Current Drug Targets-Infectious Disorders, Bentham Science Publishers Ltd, 2005.
5. Altfeld M, Allen TM, Yu XG, Johnston MN, Agrawal D, Korber BT, Montefiori DC, O'Connor DH, Davis BT, Lee PK, Maier E, Harlow J, Goulder PJR, Brander C, Rosenberg ES, Walker BD, HIV-1 superinfection despite broadly directed CD8+ T cell responses containing replication of the primary virus, Nature 420:434-439, 2002.
6. Gottlieb GS, Nickle DC, Jensen MA, Wong KG, Grobler J, Li F, Liu SL, Rademeyer C, Learn GH, Karim SS, Williamson C, Corey L, Margolick JB, Mullins JI, Dual HIV-1 infection associated with rapid disease progression, Lancet 363:1166, 2004.
7. Moghadas SM, Gumel AB, McLeod R.G, Gordon R, Could condoms stop the AIDS epidemic, J Theor Med 5:171-181, 2003.
8. McNeill ET, Gilmore CE, Finger WR, Lewis JH, Schellstede WP, The Latex Condom: Recent Advances, Future Directions, FHI, Durham, North Carolina, 2001 (www.fhi.org/en/fp/fpother/conom/index.html).
9. Reproductive Health Outlook (RHO), http://www.AIDS/HIV-AIDS Special Focus -Condoms.htm (2005).
10. WHO/UNAIDS, The Male Latex Condom, Condom Programming Fact Sheets, WHO, Geneva, 2001.
11. WHO, Scaling up Antiretroviral Therapy in Resource Limited Settings: Guidelines for a Public Health Approach, WHO, 2002.
12. Velasco-Hernández JX, Gershengorn HB, Blower SM, Could widespread use of combination antiretroviral therapy eradicate HIV epidemics, Lancet Infect Dis 2:487-493, 2002.
13. Blower SM, Gershengorn HB, Grant R.M, A tale of two futures: HIV and antiretroviral therapy in San Francisco, Science 287:650-654, 2000.
14. Kribs-Zaleta CM, Velasco-Hernández JX, A simple vaccination model with multiple endemic states, Math Biosci 164:183-201, 2000.
15. Newman P, Duan N, Rudy E, Roberts K, HIV risk and prevention in a post-vaccine context, Vaccine 22:1954-1963, 2004.
16. Elbasha EH, Gumel AB, Theoretical assessment of public health impact of imperfect prophylactic HIV vaccines with therapeutic benefits, Bull Math Biol, to appear.
17. Blower SM, McLean AR, Prophylactic vaccines, risk behaviour change, and the probability of eradication in San Francisco, Science 265:1451-1454, 1994.
18. Hsieh YH, Velasco-Hernández JX, Community treatment of HIV-1: initial stage and asymptotic dynamics, Biosystems 35:75-81, 1995.
19. Velasco-Hernández JX, Hsieh YH, Modeling the effect of treatment and behavioral change in H1V transmission dynamics, J Math Biol 32:233-249, 1994.
20. Hsu Schmitz SF, Effects of treatment or/and vaccination on HIV transmission in homosexuals with genetic heterogeneity, Math Biosci 167:1-18, 2000.
21. Velasco-Hernández JX, Brauer F, Castillo-Chavez C, Effects of Treatment and Behavioural Changes on the Dynamics of HIV/AIDS in a Highly Active Sexually Active Population, Technical Report, 1994.
22. Greenhalgh D, Doyle M, Lewis F, A mathematical treatment of AIDS and condom use, IMA J Math Appl Med Biol 18(3):225-262, 2001.
23. McLean AR, Blower SM, Imperfect vaccines and herd immunity to HIV, Proc R Soc Land B Biol Sci 253:9-13, 1993.
24. Blower SM, McLean AR., AIDS: modeling epidemic control, Science 267:1252-1253, 1995.
25. Davenport MP, Ribeiro RM, Chao DL, Perelson AS, Predicting the impact of a nonsterilizing vaccine against human immunodeficiency virus, J Virol 78:11340-11351, 2004.
26. McCluskey CC, A model of HIV/AIDS with staged progression and amelioration, Math Biosci 181:1-16, 2003.
27. Anderson RM, Garnett GP, Low-efficacy HIV vaccines: potential for community-based intervention programmes, Lancet 348:1010-1013, 1996.
28. Gumel AB, Moghadas SM, Mickens RE, Effect of a preventative vaccine on the dynamics of HIV transmission, Commun Nonlinear Sci Numer Simul 9:649-659, 2004.
29. Del Valle S, Evangelista AM, Velasco MC, Kribs-Zaleta CM, Hsu Schmitz SF, Effects of education, vaccination and treatment on HIV transmission in homosexuals with genetic heterogeneity, Math Biosci 187:111-133, 2004.
30. Kgosimore M, Lungu EM, The effects of vaccination and treatment on the spread of HIV/AIDS, J Biol Syst 12:399-417, 2004.
31. Arino J, McCluskey CC, van den Driessche P, Global results for an epidemic model with vaccination that exhibits backward bifurcation, SIAM J Appl Math 64:260-276, 2003.
32. Arino J, Cooke KL, van den Driessche P, Velasco-Hernández J, An epidemiology model that includes a leaky vaccine with general waning function, Discr Cont Dynam Syst B 4:479-495, 2004.
33. Beretta, E, Takeuchi Y, Global stability of an epidemic with time delays, J Math Biol 33:250-260, 1995.
34. Beretta E, Kuang Y, Modeling and analysis of a marine bacteriophage infection with latency period, Nonlinear Anal 2:35-74, 2001.
35. Beretta E, Hara, T, Ma W, Takeuchi Y, Global asymptotic stability of an SIR. epidemic model with distributed time delay, Nonlinear Anal 47:4107-4115, 2001.
36. Culshaw RV, Ruan S, A delay-differential equation model of HIV infection of CD4 T-cells, Math Biosci 165:27-39, 2000.
37. Dixit NM, Perelson AS, Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay, J Theor Biol 226: 95-109, 2003.
38. Genik L, van den Driessche P, An epidemic model with recruitment-death demographics and discrete delays, Fields Inst Commun 21:238-249, 1991.
39. Kuang Y, So JWH, Analysis of a two-stage population model with space-limited recruitment, SIAM J Appl Math 55:1675-1696, 1995.
40. Kuang Y, Delay Differential Equations with Applications in Population Biology, Academic Press, New York, 1993.
41. Ma W, Takeuchi Y, Asymptotic properties of a delayed SIR. epidemic model with density dependent birth rate, Discr Cont Dynam Syst B 4:671-678, 2004.
42. Wendi W, Zhien M, Global dynamics of an epidemic model with time delay, Nonlinear And Real World Appl 3:365-373, 2002.
43. Takeuchi Y, Ma W, Beretta E, Global asymptotic properties of a delay SIR. epidemic model with finite incubation times, Nonlinear Anal 42:931-947, 2000.
44. Hsu Schmitz SF, A mathematical model of HIV transmission in homosexuals with genetic heterogeneity, J Theor Med 2:285-296, 2000.
45. Hsu Schmitz SF, Effects of genetic heterogeneity on HIV transmission in homosexual populations, in Castillo-Chavez C, Blower S, van den Driessche P, Kirschner D, Yakubu A-A (eds.), Mathematical Approaches for Emerging and Re-emerging Infectious Diseases: Models, Methods and Theory, Springer-Verlag, pp. 245-260, 2002.
46. Hyman JM, Stanley EA, Using mathematical models to understand the AIDS epidemic, Math Biosci 90:415-473, 1998.
47. Cooke KL, van den Driessche P, Analysis of an SEIRS epidemic model with two delays, J Math Biol 35:240-260, 1996.
48. Qiu Z, Yu J, Zou Y, The asymptotic behaviour of a chemostat model, Discr Cont Dynam Syst B 4(3):721-727, 2004.
49. 0 in models for infectious diseases in heterogeneous populations, J Math Biol 28:365-382, 1990.
50. van den Driessche P, Watmough J, Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission, Math Biosci 180:29-48, 2002.
51. Thieme HR., Uniform persistence and permanence for non-autonomous semiflows in population biology, Math Biosci 166:173-201, 2000.
52. Thieme HR, Persistence under relaxed point-dissipativity (with application to an endemic model), SIAM J Math Anal 24(2):405-435, 1993.
53. Kribs-Zaleta CM, Structured models for heterosexual disease transmission, Math Biosci 160:83-108, 1999.
54. Dushoff J, Huang W, Castillo-Chavez C, Backwards bifurcations and catastrophe in simple models of fatal diseases, J Math Biol 36:227-248, 1998.
55. Alexander ME, Bowman C, Gumel AB, Moghadas SM, Sahai BM, Summers R, A vaccination model for transmission dynamics of influenza, SIAM J Appl Dynam Syst 3:503-524, 2004.
56. Hyman JM, Li J, Stanley EA, The differential infectivity and staged progression models for the transmission of HIV, Math Biosci 155:77-109, 1999.
57. Karmon E, Potts M, Getz WM, Microbicides and HIV: help or hindrance? J Acquir Immune Defic Syndr 34:71-75, 2003.
58. Anderson RM, Gupta S, May RM, Potential of community-wide chemotherapy or immunotherapy to control the spread of HIV-1, Nature 350:356-359, 1991.
59. Fang CT, Hsu HM, Twu SJ, Chen MY, Chang YY, Hwang JS, Wang JD, Chuang CY, Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan, J Infect Dis 190(5):879-885, 2004.
60. Hsieh YH, Sheu SP, The effects of density-dependent treatment and behavior changes on the dynamics of HIV transmission, J Math Biol 43:69-80, 2001.
61. Baggaley RF, Ferguson NM, Garnett GP, The epidemiological impact of antiretroviral use predicted by mathematical models: a review, Ernerg Themes Epidemiol 2:9, 2005.
62. Gregson S, Garnett GP, Nyamukapa CA, Hallett TB, Lewis JJ, Mason PR., Chandiwana SK, Anderson RM, HIV decline associated with behavior change in eastern Zimbabwe, Science 311:664-666, 2006.